From: Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells
Cells
Control-group
Bestatin-group
HRA
13.8 ± 0.8
15.8 ± 2.5
SKOV-3
29.0 ± 3.0
*36.1 ± 6.5 (days)